TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy.

Marianna Sabatino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.